- This event has passed.
BioMelbourne Network Annual General Meeting and Networking Event 2019
November 14, 2019 @ 4:00 pm - 6:30 pm AEDT
Event Navigation
This event provides the chance to reflect on the achievements of the year and hear more about the future plans and initiatives for BioMelbourne Network and our vision for Melbourne.
After the short AGM, there is a networking event and each year we invite a special guest to informally share their thoughts on the future of the biotechnology, medical technology and pharmaceutical sector in Melbourne. Each year we hear from a special guest speaker. This year the guest speaker is Mark Sullivan, Founder and Managing Director, Medicines Development for Global Health.
Last year’s event had a great turnout of over a hundred valued member representatives which provided a fantastic opportunity for networking. We hope you can join us in 2019!
This is a free event and is for representatives of current BioMelbourne Network member organisations only. You can check if your organisation is a member by clicking here.
Please note that we can accommodate up to four representatives from each member organisation. Feel free to register below and we’ll let you know if your organisation has reached its quota.
When: Thursday 14 November
Time: Registration at 3.45 pm for a 4.00 pm sharp start to the Annual General Meeting, followed by Networking Event until 6.30 pm
Where: EY, Level 23, 8 Exhibition Street, Melbourne
RSVP: by Friday 8th November
Special guest speaker: Mark Sullivan, Founder and Managing Director, Medicines Development for Global Health
Hosted by:
Mark Sullivan, Founder and Managing Director, Medicines Development for Global Health
Mark was previously a clinical programme head at GSK in London, Associate Director, Clinical at Gilead Sciences in California, and Chief Operating Officer of Australia’s vaccine design and development consortium at the University of New South Wales. He has contributed to three successful global registrational programs for HIV and hepatitis B therapeutics, has worked on 40 small molecule and biologic development programs at all stages, and led the development of moxidectin through FDA approval. Mark is the 2019 Victorian Australian of the Year.
